Entrada Therapeutics, Inc.
TRDA
17 insider filings · Latest: Jun 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 21 8:31 PM | Bernhardt G ZeiherDirector | Purchase | 5,000 | $5.86 | $29.3K | 5,000(I) | View → |
| May 4, 2026 | May 4 11:25 PM | Natarajan SethuramanPresident, Research & Develop. | Sale | 25,907 | $15.39 | $398.8K | 216,317(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Sale | 15,000 | $15.33 | $230.0K | 198,588(D) | View → |
| May 4, 2026 | May 4 8:33 PM | NATHAN DOWDEN | Proposed Sale | 15,000 | $14.50 | $217.5K | — | View → |
| May 4, 2026 | May 4 8:32 PM | NATARAJAN SETHURAMAN | Proposed Sale | 25,907 | $14.50 | $375.7K | — | View → |
| Apr 1, 2026 | Apr 2 8:39 PM | Kory James WentworthChief Financial Officer | Sale | 2,500 | $12.95 | $32.4K | 119,010(D) | View → |
| Apr 1, 2026 | Apr 1 8:38 PM | KORY WENTWORTH | Proposed Sale | 2,500 | $12.62 | $31.6K | — | View → |
| Mar 10, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 11,894 | $13.05 | $155.2K | 198,588(D) | View → |
| Mar 9, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 3,116 | $13.02 | $40.6K | 210,482(D) | View → |
| Mar 10, 2026 | Mar 11 8:34 PM | Kory James WentworthChief Financial Officer | Sale | 11,388 | $13.02 | $148.2K | 121,510(D) | View → |
| Mar 9, 2026 | Mar 11 8:34 PM | Kory James WentworthChief Financial Officer | Sale | 5,089 | $13.00 | $66.2K | 132,898(D) | View → |
| Mar 9, 2026 | Mar 9 8:37 PM | KORY WENTWORTH | Proposed Sale | 16,477 | $12.58 | $207.3K | — | View → |
| Mar 9, 2026 | Mar 9 8:34 PM | NATHAN DOWDEN | Proposed Sale | 15,010 | $12.58 | $188.8K | — | View → |
| Mar 4, 2026 | Mar 6 9:36 PM | Kory James WentworthChief Financial Officer | Sale | 7,988 | $12.25 | $97.9K | 137,987(D) | View → |
| Mar 4, 2026 | Mar 4 10:11 PM | KORY WENTWORTH | Proposed Sale | 7,988 | $11.85 | $94.7K | — | View → |
| Nov 21, 2025 | Nov 21 9:45 PM | KORY WENTWORTH | Proposed Sale | 8,910 | $9.17 | $81.7K | — | View → |
| Nov 14, 2025 | Nov 14 9:30 PM | 5AM Ventures V, L.P. | Proposed Sale | 200,000 | $8.80 | $1.8M | — | View → |
| Jul 9, 2025 | Jul 9 9:04 PM | 5AM Opportunities I, L.P. | Proposed Sale | 6,935 | $7.50 | $52.0K | — | View → |
| Jul 9, 2025 | Jul 9 9:02 PM | 5AM Ventures V, L.P. | Proposed Sale | 20,065 | $7.50 | $150.5K | — | View → |
| Jul 1, 2025 | Jul 1 9:03 PM | 5AM Ventures V, L.P. | Proposed Sale | 18,578 | $7.12 | $132.3K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 12 9:34 PM | Kush ParmarDirector, 10% Owner | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:17 PM | Peter S KimDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:16 PM | Gina ChapmanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:05 PM | Maha RadhakrishnanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:01 PM | Mary ThistleDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 8:52 PM | Bernhardt G ZeiherDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Option Exercise | 15,000 | $1.74 | 49,831(D) | View → |
| Mar 1, 2026 | Mar 3 11:21 PM | Dipal DoshiDirector, CEO | Grant/Award | 208,000 | $11.93 | 208,000(D) | View → |
| Mar 1, 2026 | Mar 3 11:20 PM | Kory James WentworthChief Financial Officer | Grant/Award | 66,600 | $11.93 | 66,600(D) | View → |
| Mar 1, 2026 | Mar 3 11:19 PM | Nathan J DowdenPresident & COO | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |
| Mar 1, 2026 | Mar 3 11:18 PM | Natarajan SethuramanPresident, Research & Develop. | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |